McKesson stock draws attention after North Dakota stake increase

North Dakota's State Investment Board increased its position in McKesson during the third quarter, according to a MarketBeat report published Thursday, October 29, 2026. The institutional investor bought 1,389 additional shares and held 5,064 shares after the transactions.

MarketBeat put the value of the position at USD 4.324 million at the end of the reporting period. The holding update reflects portfolio activity by an institutional investor rather than a change announced by McKesson in its pharmaceutical distribution, medical-surgical supply or technology operations.

Institutional Ownership Remains High

The North Dakota investment board's purchase was part of broader third-quarter portfolio activity among McKesson investors. MarketBeat said hedge funds and other institutional investors collectively owned 85.07 percent of the company.

The report also cited recent analyst target changes, including Mizuho's increase to USD 1,020 from USD 905 and a neutral rating. Those targets represent analyst views rather than company guidance and do not establish a new operating outlook for McKesson.

MarketBeat reported that McKesson last posted quarterly results on August 5, when revenue reached USD 105.38 billion and increased 7.7 percent year over year. The company also set fiscal 2027 earnings guidance at USD 44.20 to USD 45.00 per share, according to the report.

McKesson stock traded at 888.20 euros on Lang & Schwarz at 11:06 CET on Friday, October 30, 2026.

U.S. equity trading is shaped by developments in the S&P 500, available through current market coverage.

More ownership updates and analysis are available in More news and analyses on McKesson stock.